EPH Receptor A5 Protein (EPHA5) (AA 26-573) (His tag)

N° du produit ABIN7274558

Détail du produit

Antigène: EPH Receptor A5 (EPHA5)

Type de proteíne: Recombinant

Attributs du protein: AA 26-573

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette EPH Receptor A5 protéine est marqué à la His tag.

Fonction: Human EPHA5 Protein

Séquence: Ala26-Pro573

Attributs du produit: Recombinant Human EPHA5 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala26-Pro573.

Pureté: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Stérilité: 0.22 μm filtered

niveau d'endotoxine: Less than 1EU per μg by the LAL method.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: EPH Receptor A5 (EPHA5)

Autre désignation: EPHA5 (EPHA5 Produits)

Synonymes: CEK7 Protein, EHK-1 Protein, EHK1 Protein, EK7 Protein, HEK7 Protein, TYRO4 Protein, AI854630 Protein, AW125296 Protein, Cek7 Protein, Ehk1 Protein, Els1 Protein, Hek7 Protein, Rek7 Protein, bsk Protein, Els1. Protein, EPHA5 Protein, EPH receptor A5 Protein, Eph receptor A5 Protein, EPHA5 Protein, epha5 Protein, Epha5 Protein

Sujet: Ephrin type-A receptor 5 (EphA5) expression was detected in all non-tumor gastric epithelia but was differentially expressed among gastric cancer samples. EphA5 is differentially expressed in gastric cancer. EphA5 may therefore be a potential therapeutic target and may have clinical utility as a marker for lymph node metastasis in gastric cancer.

Poids moléculaire: 61.9 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result.

Pathways: Signalisation RTK